Terms: = Gastric cancer AND EZH2, ENX-1, 2146, ENSG00000106462, Q15910, MGC9169 AND Treatment
32 results:
1. Pharmacology and pharmacokinetics of tazemetostat.
Orleni M; Beumer JH
Cancer Chemother Pharmacol; 2024 May; 93(5):509-517. PubMed ID: 38520556
[TBL] [Abstract] [Full Text] [Related]
2. E-cadherin loss drives diffuse-type gastric tumorigenesis via ezh2-mediated reprogramming.
Zou G; Huang Y; Zhang S; Ko KP; Kim B; Zhang J; Venkatesan V; Pizzi MP; Fan Y; Jun S; Niu N; Wang H; Song S; Ajani JA; Park JI
J Exp Med; 2024 Apr; 221(4):. PubMed ID: 38411616
[TBL] [Abstract] [Full Text] [Related]
3. ezh2-interacting lncRNAs contribute to gastric tumorigenesis; a review on the mechanisms of action.
Mohebbi H; Esbati R; Hamid RA; Akhavanfar R; Radi UK; Siri G; Yazdani O
Mol Biol Rep; 2024 Feb; 51(1):334. PubMed ID: 38393645
[TBL] [Abstract] [Full Text] [Related]
4. ezh2 as a potential therapeutic target for gastrointestinal cancers.
Hashemi M; Nazdari N; Gholamiyan G; Paskeh MDA; Jafari AM; Nemati F; Khodaei E; Abyari G; Behdadfar N; Raei B; Raesi R; Nabavi N; Hu P; Rashidi M; Taheriazam A; Entezari M
Pathol Res Pract; 2024 Jan; 253():154988. PubMed ID: 38118215
[TBL] [Abstract] [Full Text] [Related]
5. Exploring the Potential Mechanism of Action of Ursolic Acid against gastric cancer and COVID-19 using Network Pharmacology and Bioinformatics Analysis.
Liu Z; Huang H; Yu Y; Jia Y; Li L; Shi X; Wang F
Curr Pharm Des; 2023; 29(16):1274-1292. PubMed ID: 37218202
[TBL] [Abstract] [Full Text] [Related]
6. Identification and validation of a novel prognostic circadian rhythm-related gene signature for stomach adenocarcinoma.
Qian L; Ding X; Fan X; Li S; Qiao Y; Zhang X; Li J
Chronobiol Int; 2023 Jun; 40(6):744-758. PubMed ID: 37122167
[TBL] [Abstract] [Full Text] [Related]
7. Identification and treatment of SMARCA4 Deficient Poorly Differentiated gastric Carcinoma.
Bhat V; Koneru M; Knapp K; Joneja U; Morrison J; Hong YK
Am Surg; 2023 Nov; 89(11):4987-4989. PubMed ID: 36533880
[TBL] [Abstract] [Full Text] [Related]
8. TGF-β1/Smad3 upregulates UCA1 to promote liver fibrosis through DKK1 and miR18a.
Yang Z; Zhang H; Yin M; Cheng Z; Jiang P; Feng M; Liu Z; Liao B
J Mol Med (Berl); 2022 Oct; 100(10):1465-1478. PubMed ID: 36001113
[TBL] [Abstract] [Full Text] [Related]
9. BMP2 inhibits cell proliferation by downregulating ezh2 in gastric cancer.
Chen Z; Yuan L; Li X; Yu J; Xu Z
Cell Cycle; 2022 Nov; 21(21):2298-2308. PubMed ID: 35856444
[TBL] [Abstract] [Full Text] [Related]
10. LncRNA CRYM-AS1 Inhibits gastric cancer Progression via Epigenetically Regulating CRYM.
Zhang P; Chen C; Zhang J; Yu X
Ann Clin Lab Sci; 2022 Mar; 52(2):249-259. PubMed ID: 35414504
[TBL] [Abstract] [Full Text] [Related]
11. Apigenin Induces Autophagy and Cell Death by Targeting ezh2 under Hypoxia Conditions in gastric cancer Cells.
Kim TW; Lee HG
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948250
[TBL] [Abstract] [Full Text] [Related]
12. ELK4-mediated lncRNA SNHG22 promotes gastric cancer progression through interacting with ezh2 and regulating miR-200c-3p/Notch1 axis.
Mao X; Ji T; Liu A; Weng Y
Cell Death Dis; 2021 Oct; 12(11):957. PubMed ID: 34663788
[TBL] [Abstract] [Full Text] [Related]
13. lncRNA THAP7-AS1, transcriptionally activated by SP1 and post-transcriptionally stabilized by METTL3-mediated m6A modification, exerts oncogenic properties by improving CUL4B entry into the nucleus.
Liu HT; Zou YX; Zhu WJ; Sen-Liu ; Zhang GH; Ma RR; Guo XY; Gao P
Cell Death Differ; 2022 Mar; 29(3):627-641. PubMed ID: 34608273
[TBL] [Abstract] [Full Text] [Related]
14. Dextran Sulfate Inhibits Cell Proliferation and Induces Apoptosis by Regulating ezh2 in gastric Carcinoma.
Huang Y; Wang W; Xu YY; Guo J; Jiao L; Wang H; Li M; Yang Q
Curr Cancer Drug Targets; 2021; 21(11):953-964. PubMed ID: 34551698
[TBL] [Abstract] [Full Text] [Related]
15. The Role of Tumor-related LncRNA PART1 in cancer.
Chen J; Meng E; Lin Y; Shen Y; Hu C; Zhou G; Yuan C
Curr Pharm Des; 2021; 27(40):4152-4159. PubMed ID: 34225608
[TBL] [Abstract] [Full Text] [Related]
16. Novel molecular targets in gastric adenocarcinoma.
Ramezankhani R; Solhi R; Es HA; Vosough M; Hassan M
Pharmacol Ther; 2021 Apr; 220():107714. PubMed ID: 33172596
[TBL] [Abstract] [Full Text] [Related]
17. LncRNA STXBP5-AS1 suppresses stem cell-like properties of pancreatic cancer by epigenetically inhibiting neighboring androglobin gene expression.
Chen S; Huang L; Li G; Qiu F; Wang Y; Yang C; Pan J; Wu Z; Chen J; Tian Y
Clin Epigenetics; 2020 Nov; 12(1):168. PubMed ID: 33160411
[TBL] [Abstract] [Full Text] [Related]
18. Exosome-transferred LINC01559 promotes the progression of gastric cancer via PI3K/AKT signaling pathway.
Wang L; Bo X; Yi X; Xiao X; Zheng Q; Ma L; Li B
Cell Death Dis; 2020 Sep; 11(9):723. PubMed ID: 32895368
[TBL] [Abstract] [Full Text] [Related]
19. Contribution of DNA methylation and ezh2 in SRBC down-regulation in gastric cancer.
Rezaei S; Hosseinpourfeizi MA; Moaddab Y; Safaralizadeh R
Mol Biol Rep; 2020 Aug; 47(8):5721-5727. PubMed ID: 32676814
[TBL] [Abstract] [Full Text] [Related]
20. Inhibition of ezh2 and activation of ERRγ synergistically suppresses gastric cancer by inhibiting FOXM1 signaling pathway.
Huang B; Mu P; Yu Y; Zhu W; Jiang T; Deng R; Feng G; Wen J; Zhu X; Deng Y
Gastric Cancer; 2021 Jan; 24(1):72-84. PubMed ID: 32529327
[TBL] [Abstract] [Full Text] [Related]
[Next]
